These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25849839)

  • 21. An investigation of the pattern of kidney injury in HIV-positive persons exposed to tenofovir disoproxil fumarate: an examination of a large population database (MHRA database).
    Danjuma MI; Mohamad-Fadzillah NH; Khoo S
    Int J STD AIDS; 2014 Mar; 25(4):273-9. PubMed ID: 24067251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nonalbumin proteinuria predominates in biopsy-proven tenofovir nephrotoxicity.
    Sise ME; Hirsch JS; Canetta PA; Herlitz L; Mohan S
    AIDS; 2015 May; 29(8):941-6. PubMed ID: 25784440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tenofovir and Severe Symptomatic Hypophosphatemia.
    Kichloo A; Chugh SS; Gupta S; Panday J; Goldar GE
    J Investig Med High Impact Case Rep; 2019; 7():2324709619848796. PubMed ID: 31142127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitochondrial dysfunction and electron transport chain complex defect in a rat model of tenofovir disoproxil fumarate nephrotoxicity.
    Ramamoorthy H; Abraham P; Isaac B
    J Biochem Mol Toxicol; 2014 Jun; 28(6):246-55. PubMed ID: 24615786
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Proximal tubular dysfunction associated with tenofovir and didanosine causing Fanconi syndrome and diabetes insipidus: a report of 3 cases.
    Irizarry-Alvarado JM; Dwyer JP; Brumble LM; Alvarez S; Mendez JC
    AIDS Read; 2009 Mar; 19(3):114-21. PubMed ID: 19334328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute renal failure in patients with AIDS on tenofovir while receiving prolonged vancomycin course for osteomyelitis.
    Psevdos G; Gonzalez E; Sharp V
    AIDS Read; 2009; 19(6):245-8. PubMed ID: 19642243
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Renal and bone effects of tenofovir-containing regimens compared in a large, real-world patient population.
    Tobin SC
    AIDS; 2017 Jul; 31(12):N17. PubMed ID: 28463886
    [No Abstract]   [Full Text] [Related]  

  • 28. Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
    Gallant JE; Parish MA; Keruly JC; Moore RD
    Clin Infect Dis; 2005 Apr; 40(8):1194-8. PubMed ID: 15791522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tenofovir-associated kidney toxicity in HIV-infected patients: a review of the evidence.
    Hall AM; Hendry BM; Nitsch D; Connolly JO
    Am J Kidney Dis; 2011 May; 57(5):773-80. PubMed ID: 21435764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medium-grade tubular proteinuria is common in HIV-positive patients and specifically associated with exposure to tenofovir disoproxil Fumarate.
    Zeder AJ; Hilge R; Schrader S; Bogner JR; Seybold U
    Infection; 2016 Oct; 44(5):641-9. PubMed ID: 27256076
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenetics of tenofovir treatment.
    Rodriguez-Novoa S; Labarga P; Soriano V
    Pharmacogenomics; 2009 Oct; 10(10):1675-85. PubMed ID: 19842939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The case: 41-year-old HIV patient with proteinuria and progressive renal dysfunction. Tenofovir toxicity.
    Agarwala R; Mohan S; Herlitz LC; Cheng JT
    Kidney Int; 2010 Mar; 77(5):475-6. PubMed ID: 20150949
    [No Abstract]   [Full Text] [Related]  

  • 33. Improvement in renal function and resolution of proteinuria in an HIV-infected patient switched from tenofovir disoproxil fumarate to tenofovir alafenamide.
    Gallagher A; Quan D; Gracey DM
    Intern Med J; 2017 Jul; 47(7):826-827. PubMed ID: 28677314
    [No Abstract]   [Full Text] [Related]  

  • 34. Assessment of the steady-state pharmacokinetic interaction between etravirine administered as two different formulations and tenofovir disoproxil fumarate in healthy volunteers.
    Kakuda TN; Schöller-Gyüre M; De Smedt G; Beets G; Aharchi F; Peeters MP; Vandermeulen K; Woodfall BJ; Hoetelmans RM
    HIV Med; 2009 Mar; 10(3):173-81. PubMed ID: 19207601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered bleeding time associated with ibuprofen and zidovudine use.
    Pieper B; Smitherman HC
    Nurse Pract; 1998 May; 23(5):74-5, 80, 83. PubMed ID: 9614682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Acute kidney injury caused by tenofovir disoproxil fumarate and diclofenac co-administration.
    Bickel M; Khaykin P; Stephan C; Schmidt K; Buettner M; Amann K; Lutz T; Gute P; Haberl A; Geiger H; Brodt HR; Jung O
    HIV Med; 2013 Nov; 14(10):633-8. PubMed ID: 23980564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute renal failure after initiation of tenofovir disoproxil fumarate.
    Hynes P; Urbina A; McMeeking A; Barisoni L; Rabenou R
    Ren Fail; 2007; 29(8):1063-6. PubMed ID: 18067059
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and genetic factors associated with kidney tubular dysfunction in a real-life single centre cohort of HIV-positive patients.
    Salvaggio SE; Giacomelli A; Falvella FS; Oreni ML; Meraviglia P; Atzori C; Clementi EGI; Galli M; Rusconi S
    BMC Infect Dis; 2017 Jun; 17(1):396. PubMed ID: 28583112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To Study the Incidence of Tenofovir Related Nephropathies in HIV Infected Patients.
    Bajpai P; Jain A; Maheshwari PK
    J Assoc Physicians India; 2020 Jan; 68(1):74. PubMed ID: 31979733
    [No Abstract]   [Full Text] [Related]  

  • 40. Tenofovir disoproxil fumarate-induced distal renal tubular acidosis: A case report.
    Salimi R; Begum I; Varma DM; Nandakrishna B; Rajesh R; Vidyasagar S
    Int J STD AIDS; 2020 Mar; 31(3):276-279. PubMed ID: 31996094
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.